Established under the Assisted Human Reproduction (AHR) Act of 2004, Assisted Human Reproduction Canada [5] (AHRC), also known as the Assisted Human Reproduction Agency of Canada, was created in 2006 to oversee research related to reproductive technologies and to protect the reproductive rights [6] and interests of Canadian citizens. AHRC serves as a regulatory body for the development and use ...

Established under the Assisted Human Reproduction (AHR) Act of 2004, Assisted Human Reproduction Canada [5] (AHRC), also known as the Assisted Human Reproduction Agency of Canada, was created in 2006 to oversee research related to reproductive technologies and to protect the reproductive rights [6] and interests of Canadian citizens. AHRC serves as a regulatory body for the development and use ...

Background: The practice of surrogacy is one of the most controversial procedures in infertility treatment. Despite increasing of using this technology in Iran, there are few practical data about surrogacy.There isn't any study assessing experiences of commissioning mothers about surrogate mother selection. Aim: The purpose of this study was exploring of commissioning mothers' experiences in se...

Advancements in assisted reproductive technology (ART) has increased the nurses' contribution to the provision of ART services. The present descriptive cross-sectional study aimed to determine essential care skills for nurses working at the selected infertility clinics in Tehran, Iran, based on their perspectives within 2016-2017. A total of 59 nurses were selected via a convenience sampling me...

Background: HLA-G is a non-classical human leukocyte antigen expressed primarily in fetal tissues at the maternal-fetal interface. The unique structure of HLA-G molecule permits a restricted peptide presentation and allows the modulation of the immune system. There is now general agreement that HLA-G is an important immunotolerant molecule with the capability of inhibiting immune cell functions...